Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade.

Respirology (Carlton, Vic.)·2026

Same author

Moving to better COPD care-changes to and challenges for GOLD.

American journal of respiratory and critical care medicine·2026

Same author

The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease.

Archivos de bronconeumologia·2026

Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026

Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026

Same author

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.

Journal of clinical medicine·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Changes in forced expiratory volume in 1 second over time in COPD.

Jørgen Vestbo¹, Lisa D Edwards, Paul D Scanlon

¹Respiratory Section, Hvidovre Hospital, Hvidovre, Denmark. jvestbo@dadlnet.dk

The New England Journal of Medicine

|October 14, 2011

Summary

The rate of lung function decline in COPD varies significantly among patients. Smoking, emphysema, and bronchodilator reversibility predict faster declines in FEV1.

More Related Videos

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

Related Experiment Videos

Last Updated: May 28, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

Area of Science:

Pulmonary Medicine
Respiratory Research
Clinical Trials

Background:

Chronic Obstructive Pulmonary Disease (COPD) is characterized by accelerated decline in forced expiratory volume in 1 second (FEV1).
Limited data exists on the variability and predictors of FEV1 decline in established COPD.
Understanding these factors is crucial for managing disease progression.

Purpose of the Study:

To analyze the rate and variability of FEV1 decline over 3 years in COPD patients.
To identify predictors of FEV1 levels and changes over time.

Main Methods:

Longitudinal analysis of FEV1 changes post-bronchodilator administration over 3 years.
Inclusion of 2163 patients with established COPD.
Application of a random-coefficient model to assess predictors.

Main Results:

The average FEV1 decline was 33 ml/year, with substantial between-patient variation (SD 59 ml/year).
Significant predictors of accelerated FEV1 decline included current smoking (21 ml/year greater decline), emphysema (13 ml/year greater decline), and bronchodilator reversibility (17 ml/year greater decline).
A notable proportion of patients (38%) experienced declines exceeding 40 ml/year.

Conclusions:

FEV1 decline in COPD is highly variable.
Current smokers, patients with emphysema, and those with bronchodilator reversibility exhibit significantly faster rates of FEV1 decline.
These findings highlight key factors influencing COPD progression.